#USA #Arlington #Bluesight #ControlCheck #PrivacyPro

Bluesight's Continued Leadership in Healthcare Solutions

In an impressive showcase of its consistent performance, Bluesight has been recognized in the 2026 Best in KLAS Software & Services report. This marks the continued leadership of Bluesight in the health system intelligence sector, particularly for its flagship solutions, ControlCheck and PrivacyPro. Both products have gained accolades based on invaluable customer feedback, solidifying Bluesight's reputation as a pioneering force in the healthcare industry.

Award-Winning Products

For the fifth consecutive year, ControlCheck has earned the title of Best in KLAS for Drug Diversion Monitoring. This robust solution provides hospitals with a comprehensive, closed-loop system for monitoring and preventing drug diversion across various settings, including nursing, inpatient care, and pharmacy workflows. Its proactive approach allows medical facilities to identify and mitigate potential risks before they escalate.

Similarly, PrivacyPro has achieved Best in KLAS for Patient Privacy Monitoring for the sixth time, showcasing its capability in safeguarding patient information against potential privacy violations. Enhanced by advanced analytics and machine learning, PrivacyPro enables compliance teams to streamline their efforts by automatically detecting high-risk behaviors, thereby allowing a more efficient allocation of resources.

Commitment to Customer-Driven Innovation

The accolades received by Bluesight highlight the strong trust that healthcare customers place in its products. Kevin MacDonald, the CEO and Co-Founder of Bluesight, remarked, "Earning Best in KLAS recognition year after year reflects the trust our customers place in Bluesight. These awards validate our commitment to our customers, innovating with purpose, and delivering solutions that help health systems reduce risk, improve safety, and operate more efficiently."

This customer-centric approach lies at the heart of Bluesight's strategy to enhance the health system's operational capabilities. The company is continually working on integrating more cross-product functionalities and expanding the responsible use of AI technologies to deliver even greater value to health system operators nationwide.

Continuous Improvement Through Feedback

What makes these distinctions particularly impressive is their foundation on direct customer feedback, as reported by KLAS Research. This input is vital for Bluesight; it informs their product development and service enhancements, ensuring that their offerings resonate with real-world needs in healthcare settings. MacDonald further emphasized, "Our teams remain focused on delivering technology that works in the real world while continually upholding our core value of honoring the customer."

Future Directions

Looking ahead, Bluesight aims to deepen product integration and forge partnerships that will enhance the capability and accessibility of its solutions for healthcare providers. This forward-thinking vision aims not only to safeguard patients but also to optimize financial performance in the healthcare sector, an increasingly important consideration in modern medical practices.

With over 3,000 hospitals relying on Bluesight's solutions daily, it's clear that its commitment to innovation and excellence is paving the way for safer and more efficient healthcare operations. For further details, the full 2026 Best in KLAS Software & Services report can be accessed through KLAS Research’s official website.

In summary, Bluesight's ongoing recognition in the Best in KLAS report underscores the effectiveness of its solutions and the company's enduring dedication to advancing health system intelligence, patient safety, and operational efficiency.